Nitric Oxide, Zinc, N-Acetylglucosamine

Manufacturer
HumanEnos LLC
Effective date
2023-02-18
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:36:18

Label at a glance#

ProductBio NO more Joint Pain (Helps improve osteoarthritis and Immunity, Soybean and oplopanax elatus Nakai fermented powder)
Active ingredientNITRIC OXIDE
Label structure8 sections

Label contents#

Full prescribing information#

DOSAGE & ADMINISTRATION SECTION

800 mg X 120
/3.39 oz

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF THE REACH OF CHILDREN.

INDICATIONS & USAGE SECTION

Bio N:O more Joint Pain

WARNINGS SECTION

Warnings

OTC - PURPOSE SECTION

Bio N:O more Joint Pain

INACTIVE INGREDIENT SECTION

Inactive ingredients:

Oplopanax elatus nakai extract powder, yeast extract, crystalline cellulose

OTC - ACTIVE INGREDIENT SECTION

Active ingredients:

Nitric Oxide, Zinc, N-Acetylglucosamine

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

44

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83202-692183202-6921-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f61a0c5f-f537-580c-e053-2995a90ae88af501598c-9fcc-a203-e053-2a95a90a61482023-03-04WarningsExact identifier
spl set id: f501598c-9fcc-a203-e053-2a95a90a6148

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.